{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:32:39Z","timestamp":1792553559613,"version":"4.5.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"24","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Survival of patients with acute myeloid leukemia (AML) can be improved by allogeneic hematopoietic stem cell transplantation (allo-HSCT) because of the antileukemic activity of T and natural killer cells from the donor. However, the use of allo-HSCT is limited by donor availability, recipient age, and potential severe side effects. Similarly, the efficacy of immunotherapies directing autologous T cells against tumor cells, including T-cell recruiting antibodies, chimeric antigen receptor T-cell therapy, and immune checkpoint inhibitors are limited in AML because of multiple mechanisms of leukemia immune escape. This has prompted a search for novel immunostimulatory approaches. Here, we show that activation of adenosine 5\u2032-monophosphate\u2013activated protein kinase (AMPK), a master regulator of cellular energy balance, by the small molecule GSK621 induces calreticulin (CALR) membrane exposure in murine and human AML cells. When CALR is exposed on the cell surface, it serves as a damage-associated molecular pattern that stimulates immune responses. We found that GSK621-treated murine leukemia cells promote the activation and\u00a0maturation of bone marrow\u2013derived dendritic cells. Moreover, vaccination with GSK621-treated leukemia cells had a protective effect in syngeneic immunocompetent recipients bearing transplanted AMLs. This effect was lost in recipients depleted of CD4\/CD8\u00a0T\u00a0cells. Together, these results demonstrate that AMPK activation by GSK621 elicits traits of immunogenic cell death and promotes a robust immune response against leukemia. Pharmacologic AMPK activation thus represents a new potential target for improving the activity of immunotherapy in AML.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2022009444","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T16:01:19Z","timestamp":1698681679000},"page":"7585-7596","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["AMPK activation induces immunogenic cell death in AML"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-5195","authenticated-orcid":false,"given":"Johanna","family":"Mondesir","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"},{"name":"2Universit\u00e9 Paris Cit\u00e9, Institut Cochin, CNRS UMR8104, INSERM U1016, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ghisi","sequence":"additional","affiliation":[{"name":"3Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Inserm U1037, CNRS U5077, Universit\u00e9 de Toulouse, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Toulouse, France"},{"name":"4LabEx Toucan, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poillet","sequence":"additional","affiliation":[{"name":"3Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Inserm U1037, CNRS U5077, Universit\u00e9 de Toulouse, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Toulouse, France"},{"name":"4LabEx Toucan, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bossong","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9558","authenticated-orcid":false,"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[{"name":"5Universit\u00e9 de Paris Cit\u00e9, Sorbonne Universit\u00e9, INSERM UMR1138, Centre de Recherche des Cordeliers, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Paris, France"},{"name":"6Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[{"name":"5Universit\u00e9 de Paris Cit\u00e9, Sorbonne Universit\u00e9, INSERM UMR1138, Centre de Recherche des Cordeliers, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Paris, France"},{"name":"6Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"7Institut du Cancer Paris CARPEM, Department of Biology, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-2032","authenticated-orcid":false,"given":"Jean-Emmanuel","family":"Sarry","sequence":"additional","affiliation":[{"name":"3Centre de Recherches en Canc\u00e9rologie de Toulouse (CRCT), Inserm U1037, CNRS U5077, Universit\u00e9 de Toulouse, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Toulouse, France"},{"name":"4LabEx Toucan, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0167-5996","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Tamburini","sequence":"additional","affiliation":[{"name":"2Universit\u00e9 Paris Cit\u00e9, Institut Cochin, CNRS UMR8104, INSERM U1016, \u00c9quipe labellis\u00e9e Ligue contre le cancer, Paris, France"},{"name":"8Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland"},{"name":"9Swiss Cancer Center Leman, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-0226","authenticated-orcid":false,"given":"Andrew A.","family":"Lane","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"2","key":"2023122214571132400_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.2019001239","article-title":"How I treat acute myeloid leukemia in the era of new drugs","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2023122214571132400_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/bmt.2011.138","article-title":"Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation","volume":"47","author":"Bokhari","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2023122214571132400_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbmt.2019.10.015","article-title":"Role of age and hematopoietic cell transplantation-specific comorbidity index in myelodysplastic patients undergoing an allotransplant: a retrospective study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation","volume":"26","author":"Carr\u00e9","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2023122214571132400_bib4","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41375-021-01253-x","article-title":"T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments","volume":"35","author":"Daver","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"2023122214571132400_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"2023122214571132400_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"issue":"12","key":"2023122214571132400_bib7","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/s12276-020-00540-4","article-title":"Interactions between tumor-derived proteins and Toll-like receptors","volume":"52","author":"Jang","year":"2020","journal-title":"Exp Mol Med"},{"issue":"4","key":"2023122214571132400_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat Immunol"},{"issue":"8","key":"2023122214571132400_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","article-title":"eIF2alpha phosphorylation is pathognomonic for immunogenic cell death","volume":"25","author":"Bezu","year":"2018","journal-title":"Cell Death Differ"},{"issue":"8","key":"2023122214571132400_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2023122214571132400_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41422-020-0383-9","article-title":"Calreticulin and cancer","volume":"31","author":"Fucikova","year":"2021","journal-title":"Cell Res"},{"issue":"1","key":"2023122214571132400_bib12","doi-asserted-by":"crossref","first-page":"110197","DOI":"10.1016\/j.celrep.2021.110197","article-title":"AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia","volume":"38","author":"Grenier","year":"2022","journal-title":"Cell Rep"},{"issue":"4","key":"2023122214571132400_bib13","doi-asserted-by":"crossref","first-page":"e1278332","DOI":"10.1080\/2162402X.2016.1278332","article-title":"Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia","volume":"6","author":"Chen","year":"2017","journal-title":"Oncoimmunology"},{"issue":"9","key":"2023122214571132400_bib14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.celrep.2015.04.063","article-title":"Co-activation of AMPK and mTORC1 induces cytotoxicity in acute myeloid leukemia","volume":"11","author":"Sujobert","year":"2015","journal-title":"Cell Rep"},{"key":"2023122214571132400_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-7598-3_11","article-title":"Knockdown of human AMPK using the CRISPR\/Cas9 genome-editing system","volume":"1732","author":"Grenier","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"4","key":"2023122214571132400_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ncb3328","article-title":"LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress","volume":"18","author":"Liu","year":"2016","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2023122214571132400_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ccr.2008.03.005","article-title":"Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells","volume":"13","author":"Chen","year":"2008","journal-title":"Cancer Cell"},{"issue":"5","key":"2023122214571132400_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/09537104.2020.1797323","article-title":"Isolation of murine bone marrow by centrifugation or flushing for the analysis of hematopoietic cells - a comparative study","volume":"32","author":"Heib","year":"2021","journal-title":"Platelets"},{"issue":"1","key":"2023122214571132400_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14440\/jbm.2014.12","article-title":"A stepwise procedure for isolation of murine bone marrow and generation of dendritic cells","volume":"1","author":"Madaan","year":"2014","journal-title":"J Biol Methods"},{"issue":"3","key":"2023122214571132400_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jdermsci.2004.02.003","article-title":"Formalin-fixed tumor cells effectively induce antitumor immunity both in prophylactic and therapeutic conditions","volume":"34","author":"Obata","year":"2004","journal-title":"J\u00a0Dermatol Sci"},{"issue":"116","key":"2023122214571132400_bib21","first-page":"54270","article-title":"A\u00a0detailed protocol for characterizing the murine C1498 cell line and its associated leukemia mouse model","author":"Mopin","year":"2016","journal-title":"J\u00a0Vis Exp"},{"issue":"11","key":"2023122214571132400_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"issue":"4","key":"2023122214571132400_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","article-title":"Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia","volume":"10","author":"Somervaille","year":"2006","journal-title":"Cancer Cell"},{"issue":"5","key":"2023122214571132400_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J"},{"issue":"1","key":"2023122214571132400_bib25","doi-asserted-by":"crossref","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"3","key":"2023122214571132400_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/bcmd.1998.0201","article-title":"Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region","volume":"24","author":"Poltorak","year":"1998","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2023122214571132400_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(10)70001-2","article-title":"50 years of allogeneic bone-marrow transplantation","volume":"11","author":"Powles","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"2023122214571132400_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023122214571132400_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fonc.2020.00697","article-title":"CAR T cells for acute myeloid leukemia: state of the art and future directions","volume":"10","author":"Mardiana","year":"2020","journal-title":"Front Oncol"},{"issue":"25","key":"2023122214571132400_bib30","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1073\/pnas.1916206117","article-title":"Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia","volume":"117","author":"Lamble","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023122214571132400_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"2023122214571132400_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"issue":"8","key":"2023122214571132400_bib33","doi-asserted-by":"crossref","first-page":"1466765","DOI":"10.1080\/2162402X.2018.1466765","article-title":"PKR and GCN2 stress kinases promote an ER stress-independent eIF2alpha phosphorylation responsible for calreticulin exposure in melanoma cells","volume":"7","author":"Giglio","year":"2018","journal-title":"Oncoimmunology"},{"issue":"26","key":"2023122214571132400_bib34","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2016-08-731737","article-title":"Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients","volume":"128","author":"Fucikova","year":"2016","journal-title":"Blood"},{"key":"2023122214571132400_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"2023122214571132400_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.tcb.2020.09.002","article-title":"When endoplasmic reticulum proteostasis meets the DNA damage response","volume":"30","author":"Gonz\u00e1lez-Quiroz","year":"2020","journal-title":"Trends Cell Biol"},{"key":"2023122214571132400_bib37","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3389\/fimmu.2017.01918","article-title":"ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells","volume":"8","author":"Lecciso","year":"2017","journal-title":"Front Immunol"},{"issue":"8407","key":"2023122214571132400_bib38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(84)90900-0","article-title":"Modulation of HLA-DR antigens expression in human myeloid leukaemia cells by cytarabine and 5-aza-2\u2019-deoxycytidine","volume":"2","author":"Pinto","year":"1984","journal-title":"Lancet"},{"issue":"1","key":"2023122214571132400_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-021-01420-9","article-title":"AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR\/p38 signaling pathway","volume":"20","author":"Pokhrel","year":"2021","journal-title":"Mol Cancer"},{"key":"2023122214571132400_bib40","doi-asserted-by":"crossref","first-page":"586760","DOI":"10.3389\/fimmu.2020.586760","article-title":"Pleiotropic effects of metformin on the antitumor efficiency of immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"2023122214571132400_bib41","doi-asserted-by":"crossref","first-page":"368ra171","DOI":"10.1126\/scitranslmed.aag1298","article-title":"Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions","volume":"8","author":"Rosenblatt","year":"2016","journal-title":"Sci Transl Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/24\/7585\/2177983\/blooda_adv-2022-009444-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/24\/7585\/2177983\/blooda_adv-2022-009444-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T09:57:52Z","timestamp":1703239072000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/24\/7585\/498524\/AMPK-activation-induces-immunogenic-cell-death-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":41,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009444","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}